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Jennifer Landsberg1, Thomas Tu¨ting1, Raymond L. Barnhill2,3 and Claire Lugassy2,3Angiotropism in melanoma correlates with ulceration
and poor prognosis. It has been shown to be a marker
of pericytic mimicry, that is, the spreading of tumor
cells in a pericyte location along abluminal vascular
surfaces. Such extravascular tumor spread may
represent another form of tumor plasticity with
reversion to a neural crest cell migratory phenotype.
In a murine melanoma model, it has recently been
demonstrated that neutrophilic skin inflammation
promotes angiotropism and metastatic spread of pri-
mary melanomas. This review discusses the role of
neutrophilic inflammation in angiotropism and peri-
cytic mimicry in melanoma progression, metastasis,
tumor cell plasticity, and tumor therapeutic resistance.
Journal of Investigative Dermatology (2016) 136, 372e377; doi:10.1016/
j.jid.2015.11.013INTRODUCTION
Melanoma is one of the most aggressive cancer types because
melanoma cells tend to metastasize early into multiple organs
that can lead to death of patients. Recent experimental work
in a murine melanoma model demonstrated that neutrophilic
inflammatory responses in the skin can promote angiotrop-
ism, pericytic mimicry, and metastatic spread of primary
melanomas (Bald et al., 2014). Angiotropism and pericytic
mimicry could promote intravasation leading to intravascular
metastasis, and/or extravascular migration of melanoma cells
and metastasis to local or more distant sites. Thus, in addition
to the classical pathway of “intravascular metastasis” of
circulating tumor cells, emerging evidence supports an
additional pathway of tumor spread along the abluminal
vascular surfaces, without entrance into vascular channels.
This process has been termed “extravascular migratory
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an open access artThis review will discuss the new field of angiotropism and
pericytic mimicry, and its links with tumor inflammation,
particularly neutrophilic infiltrates, in melanoma progression
and metastasis. It will especially articulate the idea that
angiotropism and pericytic mimicry of melanoma cells
represent a form of tumor cell plasticity with reversion to
an embryonic phenotype. It will emphasize the analogies
with extravascular migration and invasion programs occur-
ring during the neural crest cell migration in the embryo
(Lugassy et al., 2013a), and the role of inflammatory media-
tors in angiotropism and melanoma progression (Bald et al.,
2014). Finally, this review will briefly discuss the potential
role of angiotropism in resistance and recurrence after
successful targeted therapy with a Braf inhibitor (Lugassy
et al., 2014). Because lymph angiotropism of tumor cells
has not been described thus far, this review will not discuss
the role of lymphatics in melanoma progression and
dissemination.
DESCRIPTION AND DEFINITIONS OF ANGIOTROPISM
AND PERICYTIC MIMICRY IN MELANOMA
Dating back more than 15 to 20 years, Lugassy and Barnhill
have conceived and developed the field of angiotropism, peri-
cytic mimicry, and extravascular migration in melanoma
(Lugassy et al., 2013a). Specifically, the term “angiotropism”
represents a histopathological image, the term “pericytic
mimicry” refers to the replacement of pericytes by angiotropic
tumor cells, and the term “extravascular migration” is used
todescribeamechanismofprogressive tumormigrationoutside
vessels versus the “express” intravascular dissemination.
Angiotropic melanoma cells are defined histologically as
melanoma cells closely associated with the endothelium of
vascular channels in a pericytic location, and are generally
detected at the advancing front of the tumor and a prioriwithout
intravasation (Barnhill and Lugassy, 2004) (Figure 1aeb).
Ultrastructurally, angiotropic melanoma cells are linked to the
endothelium by an amorphous matrix confirmed by immuno-
histochemistry to contain laminin (Lugassy et al., 1997, 1999).
Current data have shown that angiotropism involves
both microvessels and larger vessels (Lugassy et al., 2014);
however, additional studies are needed to better discern
the involvement of mature vessels versus neovessels.
PROGNOSTIC SIGNIFICANCE OF ANGIOTROPISM,
PERICYTIC MIMICRY, AND NEUTROPHILIC
INFLAMMATION IN MELANOMA
Several studies have demonstrated that angiotropism in mela-
noma is an independent prognostic marker predicting risk for
metastasis (Bald et al., 2014; Barnhill et al., 2002; Lugassy
et al., 2011; Van Es et al., 2008; Wilmott et al., 2012).s. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. This is
icle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Angiotropism and pericytic mimicry of melanoma cells. (a) Angiotropism in a human primary melanoma. V ¼ vessel. Scale bar ¼ 50 mm. Reprinted
with permission from Barnhill and Lugassy (2004). (b) Angiotropism in a metastasis (immunostaining for MelanA and CD31). Scale bar ¼ 50 mm. (c)
Angiotropism of the neural crest stem cell migrating along the endothelial cell. Scale bar ¼ 50 mm. b and c from Lugassy et al. (2013a and 2013b). (d) Chick
chorioallantoic membrane (CAM) assay. Spreading of green fluorescent protein melanoma cells along vessels. Scale bar ¼ 1 mm. (e) Histological confirmation
of melanoma angiotropism, indicating pericytic mimicry. Scale bar ¼ 50 mm. d and e reprinted with permission from Lugassy et al. (2007). (f) Macroscopically
visible melanoma pigment spreading along dermal blood vessels in a murine melanoma model over 25 mm. Scale bar ¼ 1 mm. (g and h) Microscopic
angiotropism, indicating pericytic mimicry. (i) Similar angiotropism in a human primary melanoma. Scale bar ¼ 50 mm. fei reprinted with permission from
Bald et al. (2014). (j) Diagram of pericytic mimicry.
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demonstrated that angiotropism is significantlyassociatedwith
metastasis, ulceration, and Breslow thickness (Lugassy et al.,
2011; Wilmott et al., 2012). Ulceration of primary mela-
nomas is an adverse prognostic factor and is part of the
American Joint Committee on Cancer staging guidelines for
melanoma (Balch et al., 2009). It has been hypothesized
that ulceration may be associated with tumor-related inflam-
mation and reduced antitumor immunity (Jewell et al., 2015).
In addition, immunohistochemical staining of neutrophils in
186 primary melanomas confirmed the strong association
between ulceration and neutrophilic inflammation (Jensen
et al., 2012). Neutrophils, which are present in large
numbers in ulcerated melanomas and are known for their
proangiogenic properties, likely play an important functional
role in tumor-promoting angiogenesis (Mentzel et al., 2001).
Finally recently, in an unselected sentinel-node stage mela-
noma patient cohort (n ¼ 178), we verified that angiotropism
and lymph node metastases are associated with ulceration
and prominent neutrophilic infiltration in primary melanoma
(Bald et al., 2014).EXPERIMENTAL MODELS OF ANGIOTROPISM AND
PERICYTIC MIMICRY
Angiotropic melanoma cells replace pericytes in the vascu-
lature, a process that has been described as pericytic mimicry
(Lugassy et al., 2013a). Several experimental models have
indicated that angiotropism promotes pericytic mimicry, the
spreading and invasion of tumor cells along the abluminal
vascular surfaces in a pericytic location. In vitro, it has been
shown that cocultures of melanoma cells with endothelial
tubules resulted in angiotropism and pericytic mimicry of
melanoma cells (Lugassy et al., 2002). Live cell imaging
enabled quantitative analysis of migration (cell path length
and velocity) in single melanoma cells along vascular tubules
(Zadran et al., 2013). Ex vivo studies using rat aortic rings
(Bald et al., 2014; Lugassy et al., 2004) also resulted in
angiotropism and pericytic mimicry of melanoma cells. In a
chick chorioallantoic membrane assay (CAM) (Lugassy et al.,
2004, 2007), the spreading of melanoma cells along the
abluminal vascular surfaces was clearly demonstrated, and
histopathology confirmed the angiotropism of melanoma
cells without intravasation, as observed in human angiotropicwww.jidonline.org 373
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374melanoma (Figure 1d,e). In a murine genetically engineered
melanoma model, the distance of melanoma spread along
dermal blood vessels was more than 25 mm and histopa-
thology showed striking angiotropism, confirming pericytic
mimicry (Bald et al., 2014) (Figure 1dej).
EXTRAVASCULAR MIGRATORY METASTASIS
It is generally assumed that cells migrate passively intravas-
cularly via the blood and/or lymph. In this perspective,
angiotropism and pericytic mimicry could induce intra-
vasation and intravascular tumor dissemination (Bald et al.,
2014). In addition, it has been hypothesized that a contin-
uous migration of angiotropic melanoma could constitute an
alternative mechanism of tumor spread distinct from intra-
vascular dissemination and termed extravascular migratory
metastasis or EVMM (Lugassy et al., 2000). By this mecha-
nism, tumor cells could spread to nearby, or to more distant
sites, without entering vascular channels, representing an
alternative metastatic pathway to “the inefficient intravas-
cular metastatic process” (Talmadge and Fidler, 2010).
Importantly, vascular mimicry, a plastic, transendothelial
phenotype, has recently been shown to promote intravas-
cular metastasis (Wagenblast et al., 2015). Of interest, we
have observed a switch between vasculogenic mimicry and
pericytic mimicry in 3D culture when melanoma cells are
cocultured with endothelial tubules rather than being
cultured alone (Lugassy et al., 2013a and 2013b). It is
therefore conceivable that such a “phenotype-switch” could
occur when cells implicated in vascular mimicry are con-
nected with endothelial-lined vasculature, and that both
phenomena participate in EVMM.
Pertinent to EVMM are the origin of melanocytes from the
neural crest and the strong analogies of EVMM with neural
crest cell migration (Figure 1c), especially the migration
along vessels in the embryo (reviewed in Lugassy et al.,
2013a), suggesting that EVMM recapitulates neural crest
stem cell migration to reach secondary sites.
ANGIOTROPISM AND PERICYTIC MIMICRY: A FORM OF
MELANOMA CELL PLASTICITY
Several data strongly suggest that pericytic mimicry of
angiotropic melanoma cells in their vascular niche represent
tumor plasticity and induction of stem cell properties, in
particular neural crest cell (NCC) migration (Lugassy et al.,
2013b). Indeed, migration of NCC along the abluminal
vascular surfaces has been recently confirmed by other
authors (Lugassy et al., 2013b). Notably, frozen primary
melanomas, previously utilized for gene expression profiling,
were analyzed for angiotropism as a differential marker. This
microarray analysis identified 128 genes differentially
expressed in angiotropic versus nonangiotropic melanomas
(Lugassy et al., 2011). From the results of this microarray
analysis, 7 genes were linked to NCC migration: TCOF1,
NEIL3, AHNAK, KCTD11, HMMR, CEBPA, and AQP3. In
addition, in the study of Lugassy et al. (2013b), the interaction
between the abluminal surface of endothelial cells and
angiotropic melanoma cells triggered a differential expres-
sion of 28 genes. Among them, 20 have demonstrated
properties linked to (besides inflammation mentioned below)
cancer cell migration, cancer progression (CCL2, ICAM1,Journal of Investigative Dermatology (2016), Volume 136SELE, TRAF1, IL6, SERPINB2, and CXCL6), epithelial-
mesenchymal transition (CCL2 and IL6), embryonic/stem cell
properties (CCL2, PDGFB, EVX1, and CFDP1), and pericytic
recruitment (PDGFB). In particular, 3 of these genes are
associated with neural crest development (CCL2, PDGFB,
EVX1, and CFDP1). These data suggest that angiotropism and
pericytic mimicry induce the expression of genes linked to
embryonic/NCC migration. Finally, laminins are essential for
early embryonic development and organogenesis, and during
the course of NCC migration, specific laminins are expressed
by the basal surfaces of the epithelia lining these pathways
(Durbeej, 2010). Using a chicken CAM melanoma model, it
has been shown that several genes related to laminin were
overexpressed in angiotropic melanoma cells (Lugassy et al.,
2009). The presence of laminin between melanoma cells and
endothelial cells raises the possibility that exposed cryptic
promigratory sites on laminin trigger tumor cell migration
along the abluminal surface (Lugassy et al., 2013a).
ROLE OF NEUTROPHILIC INFLAMMATION ON
MELANOMA PLASTICITY, ANGIOTROPISM, AND
PERICYTIC MIMICRY IN MELANOMA
Neutrophilic inflammation and endothelial cell activation in
melanoma
Neutrophil organelles are packed with a cocktail of growth
factors, enzymes, and chemoattractants that, on release into
the tumor microenvironment, have a significant impact on
the existing vasculature (Tazzyman et al., 2013). One of these
proangiogenic factors is the matrix metalloproteinase-9, a
member of zinc-dependent endopeptidases that is involved
in degradation of extracellular matrix and vascular remod-
eling. The proteolytic action of matrix metalloproteinase-9
mainly regulates the bioavailability of the vascular endothe-
lial growth factor and the fibroblast growth factor 2 that are
usually sequestered in an inactive form in the extracellular
matrix (Vempati et al., 2014). It has been shown that matrix
metalloproteinase-9 from myeloid cells is required for mel-
anoma vasculogenesis (Ahn and Brown, 2008) and that ma-
trix metalloproteinase-9 has a direct effect on melanoma cell
migration (Orgaz et al., 2014). So far it has been difficult to
verify experimentally that direct release of vascular endo-
thelial growth factor from neutrophils is responsible for
increased angiogenesis after neutrophil recruitment.
Neutrophilic inflammation and melanoma invasive state
Melanoma metastases involve melanoma cell plasticity
leading to a phenotypic change from a proliferative to an
invasive, migratory state. This principally reversible “pheno-
type-switch” model of metastasis includes a decrease of
the differentiation status partly caused by decreased
expression of the melanocyte master transcription factor
microphthalmia-associated transcription factor (Hoek et al.,
2008; Hoek and Goding, 2010). Investigations on how pri-
mary mouse melanomas resist an adoptive T-cell transfer
therapy protocol targeting a melanocytic differentiation an-
tigen revealed that proinflammatory mediators like tumor
necrosis factor can shift the phenotype of melanoma cells
toward a dedifferentiated state (Ho¨lzel et al., 2013;
Landsberg et al., 2012). These data suggest that phenotype
switching may be facilitated by a proinflammatory melanoma
microenvironment.
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pericytic mimicry
Experimental evidence that neutrophilic inflammation pro-
motes angiotropism, pericytic mimicry, and metastatic spread
came from a genetically engineered melanoma model, where
neutrophilic inflammatory responses in the melanoma micro-
environment, which were induced by repetitive exposure
to sunburning doses of UV irradiation, led to selectively
increased numbers of metastases in lymph nodes and lungs
(Bald et al., 2014). Histopathologic analyses revealed strikingly
increased angiotropism in UV-irradiated melanomas with
increased local and systemic neutrophilic inflammation that
correlated with the number of lung metastases (Figures 1fel
and 2). Depletion of neutrophils or inhibition of their activation
and recruitment via an high-mobility-group-protein B1-
initiated, toll-like receptor 4- and MyD88-dependent innate
signaling pathway significantly reduced both pericyticmimicry
and the number of lung metastases. This provides the first
experimental evidence that neurophilic inflammation pro-
motes metastatic spread through enhancement of reciprocal
melanoma-endothelial interactions triggered by angiotropism.
In line with these data, it has been shown that a single UVB
irradiation of SB-2 melanoma cells induces IL-8 mRNA and
protein secretion and thereby enhances tumorigenicity and
metastatic potential on transplantation into nude mice (Singh
et al., 1995). UVB irradiation also induces IL-8 expression in
different human melanoma cells and enhances motility of
different human melanoma cells using time-lapse video-mi-
croscopy, suggesting that UVB can increase the aggressiveness
of human melanoma cells among others by the major neutro-
phil chemoattractant IL-8 (Gebhardt et al., 2007). The fact that
ulcerated melanomas show abundant neutrophils, reactive
angiogenesis, and frequently angiotropism may provide a
biological explanation for the clinical finding that ulceration of
primary human melanomas is an independent adverse prog-
nostic factor.Figure 2. Graphical abstract illustrating how neutrophilic inflammation can pr
Neutrophilic inflammation shifts melanoma cells toward a migratory phenotype
vascular surfaces, and enhances the metastatic capacity. Further investigations are
versus intravascular dissemination in melanoma progression.It has also been shown that the interaction of endothelial
tubules and melanoma cells leading to angiotropism and
pericytic mimicry in vitro triggered novel differential gene
expression, including 10 genes linked to inflammation:
CCL2, IL6, TRAF1, CXCL6, SELE, ICAM1, SLC7A2, C2CD4B,
PDGFB, and SERPINB2 (Lugassy et al., 2013b). These data
raise important questions about whether inflammation is the
cause, the result, or both of the angiotropic phenotype of
melanoma cells. Interestingly, in a murine model of brain
metastasis from lung and breast cancer, SERPINB2 has
recently been shown to promote cancer cell survival and
vascular co-option (Valiente et al., 2014), a phenomenon
most likely related to pericytic mimicry.
In addition, because laminin functions to link angiotropic
melanoma and endothelial cells, it is interesting to note the
role of neutrophil elastase and cathepsin G in laminin pro-
teolytic modification and basement membrane alterations
during inflammation (Heck et al., 1990). Furthermore,
neutrophil elastase cleaves laminin-332 (laminin-5) gener-
ating peptides that are chemotactic for neutrophils (Mydel
et al., 2008).
Using different in vitro experiments (Bald et al., 2014), we
could also demonstrate that neutrophil-conditioned media or
the proinflammatory cytokine tumor necrosis factor alone
induces migration of murine and human cells toward endo-
thelial cells in transwell assays. Inflammation also enhances
the migration distance and velocity of melanoma cells on
endothelial cell surfaces in 2D migration assays. An ex vivo
3D “ear crawl-in assay,” that was originally developed to
study dendritic cell migration in the dermal interstitium,
showed that human melanoma cells invade inflamed mouse
ear tissue explants in close association with endothelial cells,
that is, angiotropism.
In summary, neutrophil-derived tumor necrosis factor in-
duces a more migratory and angiotropic melanoma cell
phenotype in vitro and neutrophilic inflammation enhancesomote angiotropism, pericyitic mimicry, and metastasis of melanoma.
, promotes melanoma cell spreading in a pericyte location along abluminal
needed to clarify the relative importance of extravascular migratory metastasis
www.jidonline.org 375
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376angiotropism and metastatic spread in vivo. These data sup-
port the idea that neutrophilic inflammation in ulcerated
melanomas contributes to pericytic mimicry and metastasis
by shifting melanoma cells toward the migratory angiotropic
phenotype, activating endothelial cells, and fostering recip-
rocal melanoma-endothelial interactions.
RESISTANCE TO BRAF INHIBITOR THERAPY,
INFLAMMATION, AND ANGIOTROPISM
Tumor cell plasticity leads to cancer cells with stem cell
properties that are often resistant to therapy, and angiotropic
melanoma cells in their vascular niche overexpress genes
related to stem cell properties (Lugassy et al., 2013a). Resis-
tance to (V600E) B-RAF kinase inhibitor emerges in part by
melanoma cells upregulating platelet-derived growth factor
receptor, beta polypeptide (PDGFRB) (Shi et al., 2011; Sun
et al., 2014) and PDGFRB has been associated with angio-
tropic melanoma cells (Lugassy et al., 2013a). In a pre-
liminary study, it has been shown that PDGFRB was
expressed by angiotropic melanoma cells occupying a peri-
cytic location in several metastatic samples from BRAF-
resistant recurrences, versus the absence of such expression
before the onset of resistance (Lugassy et al., 2014). Notably,
the most frequent anti-BRAF therapy side effects are inflam-
matory dermatoses (Filitis and Mahalingam, 2013) charac-
terized by a neutrophil-rich skin infiltrate, which is known to
induce angiotropism and melanoma progression (Bald et al.,
2014). Ongoing studies are aimed to verify the hypothesis
that neutrophilic inflammation and angiotropism could be
implicated in the resistance to BRAF inhibitor therapy.
CONCLUSIONS
Emerging evidence supports the idea that neutrophilic
inflammation increases melanoma cell plasticity and facili-
tates the reactivation of migration and invasion programs that
are observed in their neural crest precursor cells during em-
bryonic development, in particular angiotropic migration.
This inflammation-induced angiotropism and pericytic
mimicry may provide a biological explanation for the clinical
finding that ulceration of primary human melanomas is an
independent negative prognostic factor. The emerging field of
angiotropism and pericytic mimicry clearly mandates much
more research as to (i) the precise molecular mechanism of
this angiotumoral association and (ii) the relative importance
of extravascular migratory metastasis versus intravascular
dissemination in melanoma progression. Our ultimate goal is
to define new molecular targets to reduce or prevent mela-
noma metastasis.
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